Pub Date : 2025-12-09DOI: 10.1016/j.mpdhp.2025.11.001
Joseph J. Maleszewski
Amyloidosis is a broad class of diseases all of which result in deposition of misfolded extracellular protein that result in organ dysfunction. Once considered a rare condition, cardiac amyloidosis is increasingly being identified in the ageing population and is responsible for significant morbidity and mortality, often mediated through heart failure. Our understanding of the disease, both from epidemiologic and pathobiologic perspectives has improved tremendously over the last decade, owing to greatly improved screening techniques as well as highly specific proteomic means of amyloid classification. Along with these advances, has come a host of revolutionary treatment strategies that have the potential to change the prognosis in heart failure patients. This review provides an overview of the relevant clinical issues that surround cardiac amyloidosis and is intended to update the reader on the contemporary diagnostic and therapeutic strategies for these patients.
{"title":"Cardiac amyloidosis: a clinical and pathological review","authors":"Joseph J. Maleszewski","doi":"10.1016/j.mpdhp.2025.11.001","DOIUrl":"10.1016/j.mpdhp.2025.11.001","url":null,"abstract":"<div><div>Amyloidosis is a broad class of diseases all of which result in deposition of misfolded extracellular protein that result in organ dysfunction. Once considered a rare condition, cardiac amyloidosis is increasingly being identified in the ageing population and is responsible for significant morbidity and mortality, often mediated through heart failure. Our understanding of the disease, both from epidemiologic and pathobiologic perspectives has improved tremendously over the last decade, owing to greatly improved screening techniques as well as highly specific proteomic means of amyloid classification. Along with these advances, has come a host of revolutionary treatment strategies that have the potential to change the prognosis in heart failure patients. This review provides an overview of the relevant clinical issues that surround cardiac amyloidosis and is intended to update the reader on the contemporary diagnostic and therapeutic strategies for these patients.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 2","pages":"Pages 67-76"},"PeriodicalIF":0.0,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1016/j.mpdhp.2025.11.006
Katrina Z Freimane, Kenal Patel, Kathryn J Griffin
A 35-year-old white male with no medical history was found unresponsive. A postmortem examination revealed an enlarged heart showing left ventricular thickening and diffuse pale areas. Hilar lymphadenopathy was noted, and numerous white-tan nodules were present throughout the lungs and spleen, and, focally, in the liver. Postmortem toxicology testing revealed no significant findings. Histology demonstrated extensive non-caseating granulomas with multinucleated giant cells, asteroid bodies, Schaumann bodies and lymphocytic inflammation within the heart, lungs, spleen, lymph nodes and the liver. Sections of the heart also showed widespread fibrosis. A diagnosis of systemic sarcoidosis with cardiac involvement was offered, which likely lead to a fatal cardiac arrhythmia. This case highlights the importance of meticulous postmortem evaluation in suspected sudden cardiac deaths, as this will inform whether genetic testing for inherited cardiac conditions should be offered to the family of the deceased. A comprehensive work-up of a case with suspected sudden cardiac death should include histology, toxicology and consideration of the need to retain spleen for future genetic testing.
{"title":"Cardiac sarcoidosis, a cause of sudden cardiac death","authors":"Katrina Z Freimane, Kenal Patel, Kathryn J Griffin","doi":"10.1016/j.mpdhp.2025.11.006","DOIUrl":"10.1016/j.mpdhp.2025.11.006","url":null,"abstract":"<div><div>A 35-year-old white male with no medical history was found unresponsive. A postmortem examination revealed an enlarged heart showing left ventricular thickening and diffuse pale areas. Hilar lymphadenopathy was noted, and numerous white-tan nodules were present throughout the lungs and spleen, and, focally, in the liver. Postmortem toxicology testing revealed no significant findings. Histology demonstrated extensive non-caseating granulomas with multinucleated giant cells, asteroid bodies, Schaumann bodies and lymphocytic inflammation within the heart, lungs, spleen, lymph nodes and the liver. Sections of the heart also showed widespread fibrosis. A diagnosis of systemic sarcoidosis with cardiac involvement was offered, which likely lead to a fatal cardiac arrhythmia. This case highlights the importance of meticulous postmortem evaluation in suspected sudden cardiac deaths, as this will inform whether genetic testing for inherited cardiac conditions should be offered to the family of the deceased. A comprehensive work-up of a case with suspected sudden cardiac death should include histology, toxicology and consideration of the need to retain spleen for future genetic testing.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 2","pages":"Pages 102-104"},"PeriodicalIF":0.0,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.mpdhp.2025.10.007
Katie McDonald
Gestational trophoblastic disease is an umbrella term for a rare group of lesions which range from benign to malignant. Even experienced gynaecological pathologists encounter these entities infrequently, underscoring the importance of a clear and systematic diagnostic approach. This article outlines the morphology and immunocytochemical staining of trophoblast in normal gestations then malignant tumours and their mimics in depth. The differential diagnoses are split into three sub-sections. Firstly, the lesions with three trophoblast cell lineages: choriocarcinomas, molar disease, mixed tumours and their benign mimics. Secondly, tumours resembling implantation-type intermediate trophoblast: placental site trophoblastic tumour and various mimics, both primary and secondary. Thirdly, tumours resembling chorionic-type intermediate trophoblast: epithelioid trophoblastic tumours, placental site nodules, atypical placental site nodules and some rarer malignant differential diagnoses. For the patients, precise diagnosis of these different entities can allow optimal management including monitoring, chemotherapy and immune modulators, and can preserve future fertility. Ongoing and future research is discussed at the end, and a brief mention of the centralised system in the UK. This article offers a clear diagnostic approach towards trophoblastic tumours, for training and practising pathologists.
{"title":"Gestational trophoblastic disease tumours and mimics: an up-to-date review of morphology and immunocytochemistry to aid the diagnosis","authors":"Katie McDonald","doi":"10.1016/j.mpdhp.2025.10.007","DOIUrl":"10.1016/j.mpdhp.2025.10.007","url":null,"abstract":"<div><div>Gestational trophoblastic disease is an umbrella term for a rare group of lesions which range from benign to malignant. Even experienced gynaecological pathologists encounter these entities infrequently, underscoring the importance of a clear and systematic diagnostic approach. This article outlines the morphology and immunocytochemical staining of trophoblast in normal gestations then malignant tumours and their mimics in depth. The differential diagnoses are split into three sub-sections. Firstly, the lesions with three trophoblast cell lineages: choriocarcinomas, molar disease, mixed tumours and their benign mimics. Secondly, tumours resembling implantation-type intermediate trophoblast: placental site trophoblastic tumour and various mimics, both primary and secondary. Thirdly, tumours resembling chorionic-type intermediate trophoblast: epithelioid trophoblastic tumours, placental site nodules, atypical placental site nodules and some rarer malignant differential diagnoses. For the patients, precise diagnosis of these different entities can allow optimal management including monitoring, chemotherapy and immune modulators, and can preserve future fertility. Ongoing and future research is discussed at the end, and a brief mention of the centralised system in the UK. This article offers a clear diagnostic approach towards trophoblastic tumours, for training and practising pathologists.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 1","pages":"Pages 26-39"},"PeriodicalIF":0.0,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.mpdhp.2025.11.007
Tariq Marsh-Henry, Sarah Grenfell, Tim Bracey
Gastric glomus tumours can mimic gastrointestinal stromal tumour (GIST) clinically and histologically. We present a case of gastric glomus tumour which was positive for DOG1 and synaptophysin, markers typically associated with GIST and neuroendocrine tumour respectively, diagnoses far more common than the final diagnosis highlighting a potential pitfall for pathologists. The otherwise characteristic morphological features of glomus tumour, as well as molecular detection of CARMN::NOTCH2 fusion enabled confident diagnosis but emphasises the importance of comprehensive morphological, immunohistochemistry, and molecular testing to avoid misdiagnosis, particularly given that glomus tumours are at least 100 times less frequent than GIST in the stomach. The excellent prognosis following complete surgical excision underscores the clinical significance of accurate diagnosis.
{"title":"Gastric glomus tumour with positive DOG1 and synaptophysin expression: a diagnostic challenge","authors":"Tariq Marsh-Henry, Sarah Grenfell, Tim Bracey","doi":"10.1016/j.mpdhp.2025.11.007","DOIUrl":"10.1016/j.mpdhp.2025.11.007","url":null,"abstract":"<div><div>Gastric glomus tumours can mimic gastrointestinal stromal tumour (GIST) clinically and histologically. We present a case of gastric glomus tumour which was positive for DOG1 and synaptophysin, markers typically associated with GIST and neuroendocrine tumour respectively, diagnoses far more common than the final diagnosis highlighting a potential pitfall for pathologists. The otherwise characteristic morphological features of glomus tumour, as well as molecular detection of CARMN::NOTCH2 fusion enabled confident diagnosis but emphasises the importance of comprehensive morphological, immunohistochemistry, and molecular testing to avoid misdiagnosis, particularly given that glomus tumours are at least 100 times less frequent than GIST in the stomach. The excellent prognosis following complete surgical excision underscores the clinical significance of accurate diagnosis.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 2","pages":"Pages 105-107"},"PeriodicalIF":0.0,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1016/j.mpdhp.2025.10.005
Eleanor McTaggart, Sophie Stenton
The placenta has long been one of the most misunderstood and neglected areas in surgical pathology. Whilst some groups have at times questioned the importance of the placenta in the medical management of pregnancy, it is now generally accepted that a fully functioning placenta is required for successful pregnancy and there has been an uptick in interest for placental examination. This article shall not only evaluate the pathological findings of some of the more common placental disorders, but it shall provide an overview of the most up to date understanding of disease processes and offer some practical advice on sampling and grading these lesions. Herein we focus on the following common entities: maternal vascular malperfusion, fetal vascular malperfusion, acute chorioamnionitis and chronic villitis of unknown aetiology. The article shall also address the placental lesion chronic histiocytic intervillositis (CHI), as, whilst rare, it can have particularly devastating consequences. CHI is present in first trimester products of conception and may be encountered by general pathologists inexperienced in placental pathology.
{"title":"Placental pathology: what not to miss","authors":"Eleanor McTaggart, Sophie Stenton","doi":"10.1016/j.mpdhp.2025.10.005","DOIUrl":"10.1016/j.mpdhp.2025.10.005","url":null,"abstract":"<div><div>The placenta has long been one of the most misunderstood and neglected areas in surgical pathology. Whilst some groups have at times questioned the importance of the placenta in the medical management of pregnancy, it is now generally accepted that a fully functioning placenta is required for successful pregnancy and there has been an uptick in interest for placental examination. This article shall not only evaluate the pathological findings of some of the more common placental disorders, but it shall provide an overview of the most up to date understanding of disease processes and offer some practical advice on sampling and grading these lesions. Herein we focus on the following common entities: maternal vascular malperfusion, fetal vascular malperfusion, acute chorioamnionitis and chronic villitis of unknown aetiology. The article shall also address the placental lesion chronic histiocytic intervillositis (CHI), as, whilst rare, it can have particularly devastating consequences. CHI is present in first trimester products of conception and may be encountered by general pathologists inexperienced in placental pathology.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 1","pages":"Pages 1-11"},"PeriodicalIF":0.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-22DOI: 10.1016/j.mpdhp.2025.10.006
Lesley Christie, Lesley M McMahon
Sporadic miscarriages occur in 10–20% of all pregnancies and affect one in four women. Products of conception (POC) are one of the commonest specimens submitted to the histopathology laboratory. The pathologist's role is to adequately sample, confirm a pregnancy and identify or exclude a molar pregnancy. This review summarises the genetic basis of the disease, key diagnostic features and ancillary investigations that can be employed to classify a gestation. Accurate and timely diagnosis of molar pregnancy ensures appropriate follow up and favourable outcomes.
{"title":"Hydatidiform moles and mimics: an up-to-date review on morphology and immunocytochemistry to aid the diagnosis","authors":"Lesley Christie, Lesley M McMahon","doi":"10.1016/j.mpdhp.2025.10.006","DOIUrl":"10.1016/j.mpdhp.2025.10.006","url":null,"abstract":"<div><div>Sporadic miscarriages occur in 10–20% of all pregnancies and affect one in four women. Products of conception (POC) are one of the commonest specimens submitted to the histopathology laboratory. The pathologist's role is to adequately sample, confirm a pregnancy and identify or exclude a molar pregnancy. This review summarises the genetic basis of the disease, key diagnostic features and ancillary investigations that can be employed to classify a gestation. Accurate and timely diagnosis of molar pregnancy ensures appropriate follow up and favourable outcomes.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 1","pages":"Pages 12-25"},"PeriodicalIF":0.0,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-16DOI: 10.1016/j.mpdhp.2025.10.011
Anjana Kalladathil Sreenivasan, Limi Mohandas, David Milliken, Surabhi Agrawal
Atypical polypoid adenomyoma (APA) represents a rare benign endometrial lesion characterized by proliferative, atypical glands interspersed within smooth muscle bundles. It usually affects perimenopausal women and may manifest with abnormal uterine bleeding. Although most APAs behave benignly, malignant transformation – most commonly endometrioid carcinoma – has been reported in a small proportion of cases. Clear cell carcinoma arising in APA is exceptionally rare, with only isolated cases described in the literature. Cowden syndrome, an autosomal dominant disorder caused by germline mutations in the PTEN gene, confers increased lifetime risks of breast (25–50%), thyroid (3–10%), endometrial (5–10%) and colon cancer (13%). The coexistence of APA, clear cell carcinoma and Cowden syndrome is extremely rare.
{"title":"Clear cell carcinoma arising in the background of atypical polypoid adenomyoma","authors":"Anjana Kalladathil Sreenivasan, Limi Mohandas, David Milliken, Surabhi Agrawal","doi":"10.1016/j.mpdhp.2025.10.011","DOIUrl":"10.1016/j.mpdhp.2025.10.011","url":null,"abstract":"<div><div>Atypical polypoid adenomyoma (APA) represents a rare benign endometrial lesion characterized by proliferative, atypical glands interspersed within smooth muscle bundles. It usually affects perimenopausal women and may manifest with abnormal uterine bleeding. Although most APAs behave benignly, malignant transformation – most commonly endometrioid carcinoma – has been reported in a small proportion of cases. Clear cell carcinoma arising in APA is exceptionally rare, with only isolated cases described in the literature. Cowden syndrome, an autosomal dominant disorder caused by germline mutations in the PTEN gene, confers increased lifetime risks of breast (25–50%), thyroid (3–10%), endometrial (5–10%) and colon cancer (13%). The coexistence of APA, clear cell carcinoma and Cowden syndrome is extremely rare.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 1","pages":"Pages 64-66"},"PeriodicalIF":0.0,"publicationDate":"2025-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-16DOI: 10.1016/j.mpdhp.2025.10.009
Fabienne Allias, Lucie Gaillot-Durand
Gestational trophoblastic disease encompasses a range of pregnancy-related disorders including premalignant hydatidiform mole (HM), non-neoplastic tumor-like lesion and gestational trophoblastic neoplasia. Hydatidiform moles are characterized by specific morphological, immunohistochemical and genetic features. Extensive histopathological and genetic studies over the past decades have led to the description of new entities in the differential diagnosis of HM. Androgenetic/biparental mosaic/chimera (ABMC) is an abnormal pregnancy product containing a mixture of two genetically different lineages, one androgenetic and the other biparental, within individual villi. Placental mesenchymal dysplasia (PMD) is a rare placental disorder characterized by a specific association of macroscopic and microscopic findings, and its pathogenesis is complex and heterogeneous, implying epigenetic or genetic alterations in two imprinted domains on chromosome 11p15.5. ABMC is most often an incidental finding discovered during pathological examination of molar specimen but can also be demonstrated in some placentas in the context of PMD. Although ABMC and PMD can have the same ultrasound appearance, morphologic features and discordant p57 expression, they differ in definition, pathogenesis, histopathological assessment, and clinical management.
An increasing number of pathologists are now familiar with HM, but few are aware of ABMC and PMD as separate diagnoses. This review of recent findings provides a practical approach to diagnosing ABMC and PMD.
{"title":"The overlapping spectra of androgenetic/biparental mosaic/chimera and placental mesenchymal dysplasia","authors":"Fabienne Allias, Lucie Gaillot-Durand","doi":"10.1016/j.mpdhp.2025.10.009","DOIUrl":"10.1016/j.mpdhp.2025.10.009","url":null,"abstract":"<div><div>Gestational trophoblastic disease encompasses a range of pregnancy-related disorders including premalignant hydatidiform mole (HM), non-neoplastic tumor-like lesion and gestational trophoblastic neoplasia. Hydatidiform moles are characterized by specific morphological, immunohistochemical and genetic features. Extensive histopathological and genetic studies over the past decades have led to the description of new entities in the differential diagnosis of HM. Androgenetic/biparental mosaic/chimera (ABMC) is an abnormal pregnancy product containing a mixture of two genetically different lineages, one androgenetic and the other biparental, within individual villi. Placental mesenchymal dysplasia (PMD) is a rare placental disorder characterized by a specific association of macroscopic and microscopic findings, and its pathogenesis is complex and heterogeneous, implying epigenetic or genetic alterations in two imprinted domains on chromosome 11p15.5. ABMC is most often an incidental finding discovered during pathological examination of molar specimen but can also be demonstrated in some placentas in the context of PMD. Although ABMC and PMD can have the same ultrasound appearance, morphologic features and discordant p57 expression, they differ in definition, pathogenesis, histopathological assessment, and clinical management.</div><div>An increasing number of pathologists are now familiar with HM, but few are aware of ABMC and PMD as separate diagnoses. This review of recent findings provides a practical approach to diagnosing ABMC and PMD.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 1","pages":"Pages 47-60"},"PeriodicalIF":0.0,"publicationDate":"2025-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-15DOI: 10.1016/j.mpdhp.2025.10.008
Geoffrey J Maher
Gestational trophoblastic disease (GTD) comprises molar pregnancies, abnormal pregnancies that are genetically distinct from other pregnancies, and gestational trophoblastic neoplasms (GTN) that are genetically different from non-gestational tumours. A variety of ancillary assays are available to support the diagnosis of gestational trophoblastic disease. Genotyping, a molecular assay that analyses genetic variation, is the most versatile assay for diagnosing gestational trophoblastic disease as it is informative for all types of molar pregnancy and trophoblastic tumours. This article highlights clinical contexts where genotyping, most commonly short tandem repeat (STR) genotyping, is particularly informative including determining the parental origin of DNA in triploid products of conception, diagnosing recurrent molar pregnancies and identifying the gestational origin and causative pregnancy for trophoblastic tumours. While certain pitfalls are associated with STR genotyping, these can be mitigated through careful integration of relevant clinical and pathological data and, when necessary, the application of complementary ancillary techniques.
{"title":"Diagnoses where genotyping is critical in gestational trophoblastic disease and five important pitfalls","authors":"Geoffrey J Maher","doi":"10.1016/j.mpdhp.2025.10.008","DOIUrl":"10.1016/j.mpdhp.2025.10.008","url":null,"abstract":"<div><div>Gestational trophoblastic disease (GTD) comprises molar pregnancies, abnormal pregnancies that are genetically distinct from other pregnancies, and gestational trophoblastic neoplasms (GTN) that are genetically different from non-gestational tumours. A variety of ancillary assays are available to support the diagnosis of gestational trophoblastic disease. Genotyping, a molecular assay that analyses genetic variation, is the most versatile assay for diagnosing gestational trophoblastic disease as it is informative for all types of molar pregnancy and trophoblastic tumours. This article highlights clinical contexts where genotyping, most commonly short tandem repeat (STR) genotyping, is particularly informative including determining the parental origin of DNA in triploid products of conception, diagnosing recurrent molar pregnancies and identifying the gestational origin and causative pregnancy for trophoblastic tumours. While certain pitfalls are associated with STR genotyping, these can be mitigated through careful integration of relevant clinical and pathological data and, when necessary, the application of complementary ancillary techniques.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 1","pages":"Pages 40-46"},"PeriodicalIF":0.0,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-14DOI: 10.1016/j.mpdhp.2025.10.010
Brodie Crooks, Daniel T Field, Yasin Dhonye, Katherine Quiohilag
A case of uterine mesonephric-like carcinosarcoma is reported with particular emphasis on morphology, immunohistochemistry and possible diagnostic pitfalls with other entities demonstrating mesonephric morphology in the female genital tract.
{"title":"A case of uterine mesonephric-like carcinosarcoma","authors":"Brodie Crooks, Daniel T Field, Yasin Dhonye, Katherine Quiohilag","doi":"10.1016/j.mpdhp.2025.10.010","DOIUrl":"10.1016/j.mpdhp.2025.10.010","url":null,"abstract":"<div><div>A case of uterine mesonephric-like carcinosarcoma is reported with particular emphasis on morphology, immunohistochemistry and possible diagnostic pitfalls with other entities demonstrating mesonephric morphology in the female genital tract.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"32 1","pages":"Pages 61-63"},"PeriodicalIF":0.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}